Wenn Menschen mit Typ-1-Diabetes erwachsen werden

Beim Transfer in die Erwachsenenversorgung verlieren 40 % der Jugendlichen mit einem Typ-1-Diabetes den Kontakt zur Spezialmedizin, mit einem deutlich ansteigenden Risiko für eine schlechtere glykämische Kontrolle und Folgeerkrankungen. Transitionsprogramme sind nicht flächendeckend effektiv, und der zunehmende Einsatz moderner Technologien in der Kinderdiabetologie erschwert den Übergang, wie dieser Beitrag aufzeigt.

Abstract

Approximately 40 % of adolescents with type 1 diabetes lose contact with specialty care at transfer to adult care, with a marked increase in risk for poor outcomes. Adolescents showed a 2,5-fold increased risk of an HbA_1c level > 9 % after transfer, compared with adolescents who remained in pediatric care. While the use of modern technologies is rapidly increasing in pediatric diabetology, fewer resources are available to address the rapidly changing digital transformation of type 1 diabetes therapy in adult diabetology, not least because of the large number of patients with type 2 diabetes who require care. Therefore, in the transition from children with type 1 diabetes to adult medicine, disparities in resource provision for training and interpretation of new diabetes technologies now add to the problems that have been known for many years. One possible solution would be the creation of regional treatment centers with pediatric and internal medicine care for people with intensive diabetes therapy and use of diabetes technology, as well as the use of telemedicine capabilities. International comparisons show that in centers where pediatric and internal medicine diabetes teams provide age-appropriate care within the same treatment facility, the transition is much less complicated and people with type 1 diabetes benefit from shared experience in the use of diabetes technologies across the lifespan. However, the implementation of such concepts under the framework of the German health care system requires a rethinking among the involved stakeholders and does not seem promising without pressure from the affected people with type 1 diabetes.

Schlüsselwörter

Typ-1-Diabetes - Transition - Insulinpumpen - Glukosesensoren

Key words

type 1 diabetes - transition - insulin pumps - glucose sensors

Publication History

Article published online:
14 September 2021

• Literatur

• 1 von Moers A, Müther S, Findorff J. Transition als dringliche und gemeinsame Aufgabe. Monatsschr Kinderheilkd 2018; 166: 733-743
• 2 Biester T, Kordonouri O, Datz N. et al. Neues in der Therapie des Typ-1-Diabetes-mellitus im Kindes- und Jugendalter. Monatsschr Kinderheilkd 2020; 168: 53-66
• 3 Rawshani A, Sattar N, Franzén S. et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet 2018; 392: 477-486
• 4 Gutierrez-Colina AM, Corathers S, Beal S. et al. Young Adults With Type 1 Diabetes Preparing to Transition to Adult Care: Psychosocial Functioning and Associations With Self-Management and Health Outcomes. Diabetes Spectr 2020; 33: 255-263
• 5 Schultz AT, Smaldone A. Components of Interventions That Improve Transitions to Adult Care for Adolescents With Type 1 Diabetes. J Adolesc Health 2017; 60: 133-146
• 6 Müther S, Oldhafer M, Siegmind B. Transitionsmedizin – strukturelle Lösungsansätze. Der Internist 2018; 59: 1128-1132
• 7 Neu A, Bürger-Büsing J, Danne T. Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter. Diabetologie 2020; 15 (Suppl. 01) S51-S64
• 8 Biester T, Danne T, Kordonouri O. Auf dem Weg zum Closed Loop – Ziel und Realität. Dtsch Med Wochenschr 2017; 142: 731-736
• 9 Deutsche Diabetes Gesellschaft (DDG) und diabetesDE – Deutsche Diabetes-Hilfe. Gesundheitsbericht Diabetes. 2021 Im Internet (Stand: 17.07.2021): https://www.diabetesde.org/system/files/documents/20201107_gesundheitsbericht2021.pdf
• 10 van den Boom L, Karges B, Auzanneau M. et al. Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017. Diabetes Care 2019; 42: 2050-2056
• 11 Biester T, Bratina N, Lange K. et al. Diabetesberatung zum Hybrid-AID-System bei Typ-1-Diabetes: neue Perspektiven und Therapieempfehlungen. Diabetologie und Stoffwechsel 2020; 15: 147-156
• 12 Danne T, Kordonouri O, Biester T. et al. Time in Range: Ein neuer Parameter – komplementär zum HbA 1c. Dtsch Arztebl 2019; 116
• 13 Van Walleghem N, MacDonald CA, Dean HJ. The Maestro Project: a patient navigator for the transition of care for youth with type 1 diabetes. Diabetes Spectr 2011; 24: 9-13
• 14 Kapellen T, Müther S, Schwandt A. et al. Transition to adult diabetes care in Germany-high risk for acute complications and declining metabolic control during the transition phase. Pediatr Diabetes 2018; 19: 1094-1099
• 15 Findorff J, Müther S, von Moers A. et al. Das Berliner Transitions-Programm: Sektorübergreifendes Strukturprogramm zur Transition in die Erwachsenenmedizin. Berlin: De Gruyter; 2016
• 16 Datz N, Müther S, Kordonouri O. Besonderheiten des Typ-1-Diabetes im Kindes- und Jugendalter. Diabetologe 2019; 15: 53-364
• 17 Roeper M, Reinauer C, Biester T. et al. Transition von Jugendlichen mit Diabetes in die Erwachsenenbetreuung – eine Expertenbefragung. Diabetologie und Stoffwechsel 2021; 16: 141-114
• 18 Witsch M, Kosteria I, Kordonouri O. et al. SWEET Group.Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience. Pediatr Diabetes 2016; 17 (23) 7-15
• 19 Mul D, Veeze HJ. [Virtual paediatric medicine]. Ned Tijdschr Geneeskd 2014; 158: A8267
• 20 Heyden JCV, Birnie E, Bovenberg SA. et al. Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care. Exp Clin Endocrinol Diabetes 2019;